About China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP)
China Nuokang Bio-Pharmaceutical Inc. is a biopharmaceutical company focused on research, development, manufacture, marketing and sales of hospital-based medical products. As of December 31, 2010, it sold a portfolio of 15 products, including four principal products: Baquting, its bleeding control product; Kaitong, its lipid emulsion alprostadil product for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis; Aiduo, its cardiovascular stress imaging agent, and Aiwen, its anti-arrhythmic agent. Its product pipeline includes three product candidates under development for bleeding control and hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. In February 2013, it announced the completion of the merger with Kingbird Mergerco. Inc., a wholly owned subsidiary of Kingbird Investment Inc. As a result of the merger the Company became a wholly owned subsidiary of Kingbird Investment Inc.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Frequently Asked Questions
What is China Nuokang Bio-Pharmaceutical's stock symbol?
China Nuokang Bio-Pharmaceutical trades on the NASDAQ under the ticker symbol "NKBP."
Has China Nuokang Bio-Pharmaceutical been receiving favorable news coverage?
News articles about NKBP stock have trended positive this week, Accern reports. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. China Nuokang Bio-Pharmaceutical earned a daily sentiment score of 0.35 on Accern's scale. They also gave press coverage about the biopharmaceutical company an impact score of 48.19 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of China Nuokang Bio-Pharmaceutical?
Shares of NKBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is China Nuokang Bio-Pharmaceutical's stock price today?
One share of NKBP stock can currently be purchased for approximately $5.54.
How big of a company is China Nuokang Bio-Pharmaceutical?
China Nuokang Bio-Pharmaceutical has a market capitalization of $108.95 million.
How can I contact China Nuokang Bio-Pharmaceutical?
China Nuokang Bio-Pharmaceutical's mailing address is No. 18-1 East Nanping Road Hunnan Natnl New & High-tch Dvlpmnt Zone, SHENYANG, LIA 110171, China. The biopharmaceutical company can be reached via phone at +86-24-24696033.
MarketBeat Community Rating for China Nuokang Bio-Pharmaceutical (NKBP)MarketBeat's community ratings are surveys of what our community members think about China Nuokang Bio-Pharmaceutical and other stocks. Vote "Outperform" if you believe NKBP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NKBP will underperform the S&P 500 over the long term. You may vote once every thirty days.
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Analyst Ratings History
(Data available from 4/25/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Earnings History and Estimates Chart
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Insider Trading and Institutional Ownership History
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) News Headlines
No headlines for this company have been tracked by MarketBeat.com
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Income Statement, Balance Sheet and Cash Flow Statement
China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Stock Chart for Wednesday, April, 25, 2018